Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis

INTRODUCTION: Anti-TNF therapies have revolutionized the treatment of rheumatoid arthritis (RA), a common systemic autoimmune disease involving destruction of the synovial joints. However, in the practice of rheumatology approximately one-third of patients demonstrate no clinical improvement in resp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hueber, Wolfgang, Tomooka, Beren H, Batliwalla, Franak, Li, Wentian, Monach, Paul A, Tibshirani, Robert J, Van Vollenhoven, Ronald F, Lampa, Jon, Saito, Kazuyoshi, Tanaka, Yoshiya, Genovese, Mark C, Klareskog, Lars, Gregersen, Peter K, Robinson, William H
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2714123/
https://ncbi.nlm.nih.gov/pubmed/19460157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2706
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares